Introduction
MSK has a long history of collaborating with institutions and experts from around the world to advance our collective mission of ending cancer for life. Global partnerships have allowed MSK to provide access to advance treatments to underserved regions. We engage with fellow leaders across the globe to develop infrastructure in patient care, research, and education to improve our ability to understand, prevent, diagnose, and treat cancer.
The Global Cancer Disparities Initiative
In 2011, MSK launched the Global Cancer Disparities Initiative (GCDI) program to improve outcomes for people with cancer in low- and middle-income countries, with a focus on sub-Saharan Africa. Learn more.
U.S.-Australia Cancer Consortium
Following President Biden and Prime Minister Albanese’s announcement of U.S.-Australia cooperation in innovative technologies, a U.S.-Australia Cancer Consortium was formed, focusing on pioneering cancer care collaboration. Memorial Sloan Kettering Cancer Center joined the consortium to foster collaboration between the White House Cancer Moonshot, Australia’s NSW Government and other partners to facilitate innovative cancer treatments. Read more.
The MSK Kids Stavros Niarchos Foundation Global Pediatric Cancer Program
MSK Kids engage with institutions across the globe through the Stavros Niarchos Foundation Global Pediatric Cancer Program to optimize outcomes for children with cancer. The partnership expands MSK Kids influence in pediatric oncology to young patients around the world through collaborations and peer exchanges with hospitals and other healthcare providers. Learn more (link - The Stavros Niarchos Foundation Global Pediatric Cancer Program | Memorial Sloan Kettering Cancer Center).